IMO-T 2.13 CGI-T -0.07 AC-T -0.05 LNR-T 1.37 LLY-N 2.04 META-Q 0.82 NVDA-Q -0.21
Daily Stock Opinions and Ratings
Stockchase Opinions

Brian Acker, CA Vasogin VAS-T DON'T BUY Nov 20, 2003

Have no earnings and won’t for the next 3 years. Model price is $1.50.
Brian Acker, CABrian Acker, CA
No
Unlock Rating
$6.750

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Vasogin(VAS-T)

Sep 26, 2003
Prefers companies with consistent earnings. Too speculative for them.
Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. Sc
No
Unlock Rating
$7.980

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Vasogin(VAS-T)

Dec 16, 2003
They are risk model on bile tax turned negative a couple of months ago so they sold their holdings. Well-run and has an interesting product. They are in the process of being listed in the US. Wait for some strength in that sector.
David BurrowsDavid Burrows
No
Unlock Rating
$7.470

Stock price when the opinion was issued

biotechnology pharmaceutical
HOLD

Vasogin(VAS-T)

Jan 23, 2004
Have signed on with a bigger company and now have to wait for the revenues and earnings to kick in. Easy money has been made.
Peter HodsonPeter Hodson
No
Unlock Rating
$8.980

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Vasogin(VAS-T)

Mar 24, 2004
Interesting technology.
Ed HoEd Ho
No
Unlock Rating
$7.600

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Vasogin(VAS-T)

Sep 08, 2004
Top Short Doesn't feel they have a lot of R&D to show. Have a lot of cash on the books.
Andrew McCreathAndrew McCreath
No
Unlock Rating
$6.500

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Vasogin(VAS-T)

Jan 07, 2005
Have been building up their balance sheet to complete their final trials. Are now approaching a critical time. Feels the company can start to look better from here.
Robert FloydRobert Floyd
Owned
Unlock Rating
$6.450

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Vasogin(VAS-T)

Jan 17, 2005

(Top Short Sept 8/04. Sold in low $5's so he's ahead about 19%.)

Andrew McCreathAndrew McCreath
No
Unlock Rating
$6.160

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Vasogin(VAS-T)

Feb 21, 2007
This one is past the point of no return. Speculative.
Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
No
Unlock Rating
$0.430

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Vasogin(VAS-T)

Apr 19, 2007
When a biotech finds the right thing, the stock can jump like crazy. This company just had a 1 for 10 reverse split. 90% of companies that do a reverse split are still down one year later.
Benj GallanderBenj Gallander
No
Unlock Rating
$4.500

Stock price when the opinion was issued

biotechnology pharmaceutical

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

HRTG-N -0.007$18.863
EIF-T 0.37$48.84
MRK-N 0.35$78.35
MDI-T -0.11$8.3
DBM-T 0.03$6.86
Advertising

Today's Top Picks

IMO-T 2.13$88.37
CGI-T -0.07$33
AC-T -0.05$13.97
LNR-T 1.37$48.15
LLY-N 2.04$842

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

RH-N 0.12$161.25
LVMUY-… 0$109.54
NXPI-Q 0.18$170.92
DAL-N 0.07$40.92
AMD-Q -0.03$87.47

Most Recent Experts

Bruce Murray

The Murray Wealth Group

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Stockchase Insights

5i Research

Advertising
Advertising
© Stockchase Inc.